| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |